|
TMLHE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.85029999497399E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5890999949828E-08 |
| Normal-vs-Stage2 |
1.449850E-01 |
| Normal-vs-Stage3 |
3.227700E-02 |
| Normal-vs-Stage4 |
5.76119999999847E-05 |
| Stage1-vs-Stage2 |
2.620400E-01 |
| Stage1-vs-Stage3 |
3.009800E-01 |
| Stage1-vs-Stage4 |
6.231200E-01 |
| Stage2-vs-Stage3 |
7.988600E-01 |
| Stage2-vs-Stage4 |
1.647450E-01 |
| Stage3-vs-Stage4 |
1.834180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.07610001096748E-09 |
| Normal-vs-AfricanAmerican |
1.538440E-03 |
| Normal-vs-Asian |
7.706800E-01 |
| Caucasian-vs-AfricanAmerican |
3.989800E-02 |
| Caucasian-vs-Asian |
5.360600E-01 |
| AfricanAmerican-vs-Asian |
7.486400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.77309994148823E-10 |
| Normal-vs-Female |
3.297800E-02 |
| Male-vs-Female |
6.23140000000078E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.67780000000551E-05 |
| Normal-vs-Extreme_Weight |
1.26260002453193E-09 |
| Normal-vs-Obese |
3.391400E-04 |
| Normal-vs-Extreme_Obese |
8.1494999999987E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.038240E-01 |
| Normal_Weight-vs-Obese |
4.960000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.034600E-01 |
| Extreme_Weight-vs-Obese |
1.237760E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.599000E-01 |
| Obese-vs-Extreme_Obese |
1.600840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.329200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.07569999996393E-06 |
| Normal-vs-Age(61-80Yrs) |
8.75329997374052E-09 |
| Normal-vs-Age(81-100Yrs) |
4.629100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.151400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.288100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.868400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.709210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.002400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.259400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16580001208177E-09 |
| Normal-VS-Type2 PRCC |
2.079500E-03 |
| Normal-VS-KIRP CIMP |
3.088800E-01 |
| Normal-VS-Unclassified PRCC |
1.415400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.119770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.932100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.292400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.368800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.379200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.461800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.999500E-04 |
| Normal-vs-N1 |
5.239000E-04 |
| Normal-vs-N2 |
2.962000E-03 |
| N0-vs-N1 |
9.644200E-01 |
| N0-vs-N2 |
5.944800E-01 |
| N1-vs-N2 |
4.604600E-01 |
|
|
